NASDAQ
Oculis Holding AG - Ordinary shares (OCS)
♥ 516 Thanks from members
Oculis Holding AG demonstrates strong clinical and capital momentum driven by its neuro-ophthalmology pivot, highlighted by Privosegtor's acquisition and robust cash runway into 2H 2029, though tempered by prior Phase 3 setbacks.